Furthermore, scRNA-seq comparison of CD34+ BM cells at diagnosis from CR vs non-CR AML patients revealed that a cluster of GMP cells characterized by CRIP1highLGALS1highS100Ashigh was significantly enriched in non-CR samples and associated with poor prognosis of AML (110). This evidence concerns the gene CD34 and acute myeloid leukemia.